D-0615-2026 Class II Ongoing

Recalled by Amgen, Inc. — Thousand Oaks, CA

FDA drug recall D-0615-2026 was initiated by Amgen, Inc. on Jun 4, 2026 and is designated Class II. Reason for recall: Presence of Foreign Substance. The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Jul 1, 2026
Initiation Date
Jun 4, 2026
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Corlanor (ivabradine) tablets, 7.5mg, 60-count bottles, Rx Only, Amgen Inc., Thousand Oaks, CA 92130 Made In Italy. NDC 55513-810-60

Reason for recall

Presence of Foreign Substance.

Distribution pattern

Nationwide within the United States

Code information

Lot #: 1138203, 1142065, Exp. Date 07/31/2026; 1145151, 1145152, 1145153, Exp. Date 2/28/2027; 1148908, 1148909, Exp. Date 05/31/2027; 1162845, 1162846, Exp. Date 11/30/2027; 1166471, 1166472, 1166473, Exp. Date 05/31/2028; 1170615, Exp. Date 08/31/2028

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0615-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0615-2026. Report a data issue: hello@regdatalab.com.